SI-BONE, Inc. (SIBN)
Automate Your Wheel Strategy on SIBN
With Tiblio's Option Bot, you can configure your own wheel strategy including SIBN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SIBN
- Rev/Share 4.4822
- Book/Share 3.9855
- PB 4.0798
- Debt/Equity 0.214
- CurrentRatio 7.9716
- ROIC -0.1214
- MktCap 705541790.0
- FreeCF/Share -0.2458
- PFCF -66.454
- PE -32.2797
- Debt/Assets 0.1572
- DivYield 0
- ROE -0.1286
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | SIBN | TD Cowen | -- | Buy | -- | $21 | Jan. 27, 2026 |
News
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
Published: February 02, 2026 by: GlobeNewsWire
Sentiment: Neutral
SANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the fourth quarter and full year ended December 31, 2025 after market close on Monday, February 23, 2026.
Read More
Should You Buy Si-Bone (SIBN) After Golden Cross?
Published: December 05, 2025 by: Zacks Investment Research
Sentiment: Positive
After reaching an important support level, SiBone (SIBN) could be a good stock pick from a technical perspective. SIBN recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
Read More
DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of SI-Bone, Inc. Customers Whose Data May Have Been Compromised
Published: October 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEWTOWN, Pa., Oct. 03, 2025 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at SI-Bone, Inc. (“SI-Bone”).
Read More
SI-BONE, Inc. (SIBN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Published: September 09, 2025 by: Seeking Alpha
Sentiment: Neutral
SI-BONE, Inc. (NASDAQ:SIBN ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:00 AM EDT Company Participants Laura Francis - CEO & Director Anshul Maheshwari - Chief Financial Officer Presentation Unknown Analyst All right. Good morning.
Read More
All You Need to Know About Si-Bone (SIBN) Rating Upgrade to Buy
Published: July 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Si-Bone (SIBN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Wall Street Analysts See a 34.22% Upside in Si-Bone (SIBN): Can the Stock Really Move This High?
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 34.2% in Si-Bone (SIBN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
What Makes Si-Bone (SIBN) a Strong Momentum Stock: Buy Now?
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Si-Bone (SIBN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
Wall Street Analysts Think Si-Bone (SIBN) Could Surge 41.21%: Read This Before Placing a Bet
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
The consensus price target hints at a 41.2% upside potential for Si-Bone (SIBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read More
SI-BONE, Inc. (SIBN) Q1 2025 Earnings Call Transcript
Published: May 05, 2025 by: Seeking Alpha
Sentiment: Neutral
SI-BONE, Inc. (NASDAQ:SIBN ) Q1 2025 Earnings Conference Call May 5, 2025 4:30 PM ET Company Participants Saqib Iqbal - VP, FP&A, Investor Relations Laura Francis - Chief Executive Officer Anshul Maheshwari - Chief Financial Officer Conference Call Participants Craig Bijou - Bank of America David Turkaly - Citizens JMP Young Li - Jefferies Caitlin Cronin - Canaccord Genuity David Saxon - Needham & Company Operator Good afternoon. And welcome to SI-BONE's First Quarter 2025 Earnings Conference Call.
Read More
SI-BONE, Inc. (SIBN) Q4 2024 Earnings Call Transcript
Published: February 24, 2025 by: Seeking Alpha
Sentiment: Neutral
SI-BONE, Inc. (SIBN) Q4 2024 Earnings Call Transcript
Read More
Si-Bone (SIBN) Expected to Beat Earnings Estimates: Should You Buy?
Published: February 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Si-Bone (SIBN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
About SI-BONE, Inc. (SIBN)
- IPO Date 2018-10-17
- Website https://si-bone.com
- Industry Medical - Devices
- CEO Laura A. Francis
- Employees 349